Circulating microRNAs in hepatitis B virus-infected patients

Journal of Viral Hepatitis

Volumn 18, Issue 7, 2011, Pages

  Ji, F ^a   Yang, B ^a   Peng, X ^b   Ding, H ^c   You, H ^d   Tien, P ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

circulating miRNA; hepatitis B e antigen and hepatitis B surface antigen; hepatitis B virus; hepatitis B virus replication; miR 122

Indexed keywords

MICRORNA;

ACUTE ON CHRONIC LIVER FAILURE; ARTICLE; ASYMPTOMATIC INFECTION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CARRIER; VIRUS REPLICATION;

ADULT; ASYMPTOMATIC INFECTIONS; CELL LINE, TUMOR; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 79959594560     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01443.x     Document Type: Article

References (23)

1. Lavanchy D,. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107. (Pubitemid 38365759)
2. Hou J, Yin YK, Xu D, et al. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: results at 1 year of a randomized, double-blind trial. Hepatology 2008; 47: 447-454. (Pubitemid 351280712)
3. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P,. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005; 309: 1577-1581. (Pubitemid 41266486)
4. Huang J, Wang F, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 2007; 13: 1241-1247. (Pubitemid 47530631)
5. Lecellier CH, Dunoyer P, Arar K, et al. A cellular microRNA mediates antiviral defense in human cells. Science 2005; 308: 557-560. (Pubitemid 40570587)
6. Triboulet R, Mari B, Lin YL, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007; 315: 1579-1582. (Pubitemid 46449475)
7. Kiernan RE, Vanhulle C, Schiltz L, et al. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J 1999; 18: 6106-6118. (Pubitemid 29515686)
8. Chen CZ, Li L, Lodish HF, Bartel DP,. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86. (Pubitemid 38055775)
9. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF,. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007; 104: 7080-7085. (Pubitemid 47186012)
10. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D,. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104: 1604-1609. (Pubitemid 46214637)
11. Taganov KD, Boldin MP, Chang KJ, Baltimore D,. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486. (Pubitemid 44267285)
12. Stephen AL, Masao O, Dong JS, Adnan S,. Asia-Pacific Pocket Guide to HEPATITIS B. 2008.
13. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
14. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
15. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009; 106: 4402-4407.
16. Lok AS, McMahon BJ,. Chronic hepatitis B. Hepatology 2007; 45: 507-539. (Pubitemid 46374607)
17. Ura S, Honda M, Yamashita T, et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009; 49: 1098-1112.
18. Lewis BP, Burge CB, Bartel DP,. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20. (Pubitemid 40094598)
19. Ferrari C, Missale G, Boni C, Urbani S,. Immunopathogenesis of hepatitis B. J Hepatol 2003; 39 (Suppl. 1): S36-S42. (Pubitemid 37222646)
20. Huang B, Zhao J, Lei Z, et al. miR-142-3p restricts cAMP production in CD4+ CD25- T cells and CD4+ CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 2009; 10: 180-185.
21. Ji J, Shi J, Budhu A, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009; 361: 1437-1447.
22. Tanzer A, Stadler PF,. Molecular evolution of a microRNA cluster. J Mol Biol 2004; 339: 327-335. (Pubitemid 38596952)
23. Liaw YF,. HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B. Hepatol Int 2009; 3: 425-433.